75+ hours of CME content will be presented at the conference.
*Attendees can earn up to 21 credits of continuing medical education across multiple therapeutic areas, taught by PAINWeek faculty. Note: this count does not include any CME Satellite Symposia in which one may be able to earn additional credits onsite. Information on these specific courses will be available on the conference website with total credit hours included.*
Pharmacotherapy - up to 19 total credits/hours (Nurses and NPs need 25 Pharma credits to fulfill their recertification requirements)
MATE Act - up to 18 total credits/hours (clinicians need 8 hours to fulfill the DEA requirement. At this time, it is a one-time completion. The DEA has not released an update about an annual renewal as of date.)
Activity Overview
PAINWeek is the premier national conference for dedicated healthcare professionals committed to improving pain relief and patient outcomes. Drawing on 17 years of expertise in medical continuing education, we curate an extensive agenda showcasing the latest research and practical clinical strategies in pain management. Our transformative four-day event offers tailored learning experiences vital for pain management professionals, providing unparalleled access to indispensable information across 75+ multidisciplinary courses. Participation at PAINWeek ensures you gain essential insights and skills crucial for effective pain management in today's healthcare landscape.
Target Audience
This activity is designed for an audience of physicians, physician assistants (PAs), nurse practitioners (NPs), nurses, pharmacists, hospitalists, psychologists, and other healthcare professionals involved in pain management.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Identify sources of pain via physical and neurological examinations, laboratory tests, imaging, electrodiagnostic procedures, and appropriate psychological assessments.
- Select the appropriate methodology to evaluate chronic pain, including physical exam, clinical history, and work-up.
- Describe and apply comprehensive pharmacological and non-pharmacological pain management and treatment options for various conditions that are characterized by acute, episodic, and chronic pain symptoms.
- Employ safe, effective, and equitable pain management and treatment strategies in clinical practice.
- Employ safe and appropriate evidence-based pain management strategies in patients with multiple chronic pain conditions to minimize the risk of drug-to-drug interactions (DDIs), polypharmacy effects, and substance use disorders (SUDs).
- Employ safe and appropriate evidence-based pain management strategies in patients with multiple comorbidities.
- Recognize implicit biases in clinical practice that may impede the optimal management of pain and patient outcomes.
- Implement interprofessional team strategies for improving care coordination and communication to advance chronic pain care and improve outcomes.
- Cite current medical/legal issues impacting pain management, including updated CDC guidelines, and the ethics of consensual/nonconsensual opioid tapering.
Criteria for Success Statements of credit will be awarded based on the participant's attendance. A statement of credit will be available upon completion of an online evaluation/claim credit form. If you have questions about this CE activity, please contact AKH Inc at
[email protected].
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and PAINWeek. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 21 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 21 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurses
Credit being awarded: 21 ANCC contact hours.
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 21 contact hours.
Physician Assistant
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 21 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and PAINWeek. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 21 contact hour(s) (which includes 19 hour(s) of pharmacology).
Psychologists
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Commercial Support
PAINWeek is supported in part by educational grants from Vertex Pharmaceuticals Incorporated, Boston Scientific, and Averitas Pharma, Inc.
